Ronald P. Gladue
Pfizer Global Research and Development
Groton
Connecticut 06340
USA
Name/email consistency: medium
- CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases. Gladue, R.P., Tylaska, L.A., Brissette, W.H., Lira, P.D., Kath, J.C., Poss, C.S., Brown, M.F., Paradis, T.J., Conklyn, M.J., Ogborne, K.T., McGlynn, M.A., Lillie, B.M., DiRico, A.P., Mairs, E.N., McElroy, E.B., Martin, W.H., Stock, I.A., Shepard, R.M., Showell, H.J., Neote, K. J. Biol. Chem. (2003)